Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07209202 · ClinicalTrials.gov registry record · NA
Fructose Intestinal Gluconeogenesis
A NA study of Healthy Participants and Obese But Otherwise Healthy Participants, sponsored by Touro University, California.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07209202: Recruiting NA study of Healthy Participants and Obese But Otherwise Healthy Participants, sponsored by Touro University, California.
NCT07209202 is a NA study of Healthy Participants and Obese But Otherwise Healthy Participants that is actively recruiting participants, run by Touro University, California. The registered enrollment target is 40 participants, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07209202, a NA study of Healthy Participants and Obese But Otherwise Healthy Participants, is actively recruiting participants, sponsored by Touro University, California.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the hypothesis that within a defined range of fructose intake, the ability to convert fructose to glucose (via gluconeogenesis) in the small intestine plays a protective role for the liver, shielding it from the deleterious effects of fructose. We will investigate whether this protective effect of the intestine is impaired in individuals with obesity.
Primary Outcome
Total amount of fructose converted to glucose
Conditions Studied
Interventions
- OTHER High fructose meal
- OTHER Low fructose meal
- OTHER 13C labeled fructose, oral
- OTHER 13C labeled fructose, intravenous
Study Locations (1)
California
- Touro University California - Vallejo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-03-02 |
| Est. Completion | 2030-06 |
| Phase | NA |
What NCT07209202 shows while recruiting
NCT07209202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (38% lower).
The record links to 2 conditions, with Healthy Participants appearing as the primary indexed condition, and to 4 interventions - of which High fructose meal is the first listed.
NCT07209202 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07209202 about?
NCT07209202 is a clinical study titled "Fructose Intestinal Gluconeogenesis". This study will test the hypothesis that within a defined range of fructose intake, the ability to convert fructose to glucose (via gluconeogenesis) in the small intestine plays a protective role for the liver, shielding it from the deleterious effects of fructose. We will investigate whether this p...
What is the current status of trial NCT07209202?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-03-02. Estimated completion is 2030-06.
What conditions does trial NCT07209202 study?
This clinical trial studies the following conditions: Healthy Participants, Obese But Otherwise Healthy Participants.
What interventions are being tested in trial NCT07209202?
The interventions under investigation include: High fructose meal (OTHER), Low fructose meal (OTHER), 13C labeled fructose, oral (OTHER), 13C labeled fructose, intravenous (OTHER).
Who is sponsoring clinical trial NCT07209202?
This trial is sponsored by Touro University, California, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07209202 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07209202's enrollment target sits among peer trials
40 56th of 119 higher than 59 of 119 other Healthy Participants trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Participants trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Royal Ancient Oats™ Study
RECRUITING · NA
-
The Increasing Mindfulness Engagement Project
RECRUITING · NA
-
Testing a Non-Invasive Spinal Stimulation Device
RECRUITING · NA
-
Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts.
RECRUITING · NA
-
Effect of Limosilactobacillus Reuteri DSM 17648 in Healthy Adults Reporting Upper Gastrointestinal Discomfort
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI